This year, GLP-1 medications like Ozempic, Wegovy and Mounjaro dominate weight loss conversations.  Originally developed ...

Drugs like Ozempic and Wegovy can have a surprising impact on the brain, suggesting potential new avenues of research and ...

Doctors are learning more about the wider effects of the injections, from lowering blood pressure to helping people quit alcohol and drugs ...

The head of Zealand Pharma has called its $5.3bn partnership with Roche to commercialise an obesity drug with fewer ...

Defensive lineman Desmond Watson shed 26 pounds in less than a month, but if selected in the NFL draft would still be ...

Wellness influencer Janelle Rohner is receiving backlash after admitting to, and then apologizing for, using a weight loss ...

GLP-1 receptor agonists are effective weight-loss medications, but they may also decrease muscle mass, raising concerns about ...

Accounting for mortality as competing risk, the Afib burden trended numerically in favor of the GLP-1 RA group (HR 0.85, 95% ...

In this video at Obesity Medicine 2025, Harold E. Bays, MD, FOMA, FTOS, FACC, FASPC, FNLA, discusses highlights from his talk ...

Studies in neuroscience with applications to humans offer clues about what makes us start eating, and when we stop.

Novo Nordisk remains financially strong, but pricing pressures and CagriSema challenges limit near-term upside. Find out why ...